Loading the lesson
Loading the lesson
Search AllRounder.ai
Search the courses, subjects, tracks, games and features, or jump straight to a page.
Search the courses, subjects, tracks, games and features, or jump straight to a page.
Learn it your way
A short class with Sarah and her students. The other ways are under More.
Sign up free to listen. Transcripts are free to read.
Today, we will discuss in vivo gene therapy. Who can tell me what is meant by 'in vivo'? Remember, collaborate about the term.
In vivo means 'inside the living organism'.
Exactly! In vivo gene therapy involves introducing genes directly into a patient's body. Now, why would we prefer this method over ex vivo therapies?
It targets specific tissues without needing to remove them first!
Great point! This minimizes the need for surgical procedures. Let's remember the acronym VITA: 'V' stands for 'Viral delivery methods', 'I' for 'Immediate results', 'T' for 'Targeted therapy', and 'A' for 'Access to difficult tissues'. This will help you recall key advantages of in vivo therapies.
Now let's dive into how these genes are delivered. Who knows some methods we could use?
Modified viruses like AAV and lentivirus!
Correct! These viral vectors are engineered to deliver genetic material. What are some advantages of using them?
They can integrate into the host genome for long-term expression!
Exactly! Let's also recall the phrase 'Safety First!' This reminds us that while these methods are effective, ensuring the safety of these delivery systems is paramount.
While in vivo gene therapy is promising, it also faces numerous challenges. Can anyone name one?
What about immune responses against the viral vectors?
That's a significant challenge! The immune system may recognize the vectors as foreign. Let's remember 'HIDE', which stands for 'Host immune response', guiding our understanding of potential barriers. How might we mitigate this response?
We could use non-viral delivery methods instead!
Exactly! Non-viral methods can reduce immune complications but have their own limitations, especially in getting enough gene copies into target cells.
Let's look at some success stories! Who can tell me about an example of in vivo gene therapy?
Luxturna is an exciting one that treats a type of inherited blindness!
Right! Luxturna uses an AAV vector to deliver the RPE65 gene directly to retinal cells. We can use the mnemonic 'LUXY' to recall its key points: 'L' for 'Light perception', 'U' for 'Used in eyes', 'X' for 'X-linked', 'Y' for 'Yes, it works!'
In vivo therapy involves administering therapeutic genes directly into the organism.
Different delivery methods come with their distinct advantages and challenges.
The body's immune system can pose challenges in accepting delivered genes.
There are successful applications of in vivo gene therapies, providing hope for future treatments.
Term
In Vivo Gene Therapy
Click to flip
Term
Viral Vectors
Click to flip
Term
Immune Response
Click to flip
Term
Long-term Gene Expression
Click to flip
A method of treating disease by directly delivering genetic material into a patient's body.
Modified viruses used to deliver therapeutic genes into host cells.
Alternative delivery techniques that do not involve viruses, such as liposomes or electroporation.
A common viral vector used in gene therapy for its low immunogenicity and ability to provide long-term expression.
In Vivo gene therapy involves the direct delivery of genetic material into a patient's body to treat disease.
In Vivo gene therapy is a method that aims to deliver therapeutic genes directly to the desired tissues without prior modification of the cells outside the body. It is particularly useful for genetic and acquired disorders and comes with specific challenges regarding the delivery and expression of the genes.
In Vivo gene therapy is a pioneering medical approach that entails the direct introduction of therapeutic genes into the body to cure or mitigate diseases caused by genetic abnormalities. Unlike ex vivo methods, where cells are modified outside the patient before reintroduction, in vivo therapy delivers genes to target tissues within the body. This technique is vital for treating various conditions, including muscular dystrophy and certain eye disorders. Understanding the strategies for effective gene delivery, evaluating risks associated with immune responses, and ensuring long-term gene expression are essential components of this therapeutic approach. The chapter emphasizes the importance of continuing research and innovation in the evolving landscape of personalized medicine.